Psoriatic Arthritis Clinical Case Review

Philip Mease, MD, rheumatologist at Swedish Health Services in Washington, reveals the selected treatment for this patient.

Editor’s note: The following is an automatically generated transcript of the above video.

"So we could think about the classes of TNF inhibitors, interleukin 17 inhibitors and JAK inhibitors generally for this young woman because we know that they can beneficially affect all of the important clinical domains that she's experiencing, but if she really wants to become pregnant, then a safe bet would be to recommend certolizumab if her insurance will allow it because it is safe in pregnancy and lactation."